omniture
Porda Havas International Financial Communications Group

Latest News

LZ901, A Recombinant Herpes Zoster Vaccine And The Core Product Of Luzhu Biotechnology, Completed Phase II Clinical Trail In Q2 2023

World's First Herpes Zoster Vaccine With A Tetrameric Molecular Structure BEIJING, May 30, 2023 /PR...

2023-05-30 22:07 3197

Baguio wins an AI-powered Government Smart Toilet contract servicing at over 800 public toilets in Hong Kong

HONG KONG, May 22, 2023 /PRNewswire/ -- Baguio Green Group Limited ("Baguio" or the "Company", Stoc...

2023-05-22 20:37 2796

Baguio Green's 2022 Net Profit* Increased by 3.2 times

Contracts On Hand Recorded a Historical High with a Surge of 67% to HK$3.6 billion HONG KONG, Marc...

2023-03-30 22:01 3202

PAAMC HK Honored with Two Awards at Offshore China Fund Awards 2022

HONG KONG, March 28, 2023 /PRNewswire/ -- Ping An of China Asset Management ( Hong Kong) Company Lim...

2023-03-28 17:32 1478

Lepu Biopharma and Keymed Jointly Announces Global Exclusive Licence Agreement with AstraZeneca for CMG901

HONG KONG, Feb. 22, 2023 /PRNewswire/ -- Lepu Biopharma Co., Ltd. (Stock Code: 02157.HK) and Keymed...

2023-02-23 12:26 2528

Baguio wins EPD contract to provide Smart Recycling Machines with a Big Data Analytics Platform

HONG KONG, Feb. 20, 2023 /PRNewswire/ -- Baguio Green Group Limited ("Baguio" or the "Company", St...

2023-02-20 19:41 2381

Baguio wins EPD service contract worth HK$37 million to provide food waste collection services in New Territories West

HONG KONG, Jan. 16, 2023 /PRNewswire/ -- Baguio Green Group Limited ("Baguio" or the "Company", Sto...

2023-01-16 20:41 2770

PAAMC HK Announces Winning in ESG Leading Enterprise Awards 2022

HONG KONG, Dec. 14, 2022 /PRNewswire/ -- Ping An of China Asset Management ( Hong Kong) Company Limi...

2022-12-14 16:30 1839

Baguio wins FEHD contracts worth HK$482 million driving total Contracts on Hand to a historical high level

HONG KONG, Sept. 30, 2022 /PRNewswire/ -- Baguio Green Group Limited ("Baguio" or the "Company", St...

2022-09-30 17:51 3973

PAAMC HK Honored to be Included in 4 Prestigious IAMAC Recommendations

HONG KONG and SHANGHAI, Sept. 27, 2022 /PRNewswire/ -- Ping An of China Asset Management (Hong Kong...

2022-09-27 16:30 2491

Baguio's Net Profit Increased by 45%

Contracts On Hand Recorded a Historical High with a Substantial Increase of around 60% to HK$3.4 bi...

2022-08-30 23:01 4074

Ocumension Releases its 2022 Interim Report with its core product Youshiying® being approved for marketing, continuously accelerating product commercialization

BEIJING, Aug. 26, 2022 /PRNewswire/ -- On August 26, 2022 (Beijing time), Ocumension Therapeutics (...

2022-08-26 22:09 11647

SZSE Issued Evaluation Method of ESG and ESG Indices to Improve SZSE Characteristic Index System and Provide Services to Low-Carbon and Sustainable Development

SHENZHEN, China, Aug. 11, 2022 /PRNewswire/ -- On July 25, Shenzhen Securities Information Co., Ltd...

2022-08-11 16:33 2154

Ocumension OT-401 (Product name: YUTIO), a treatment for chronic non-infectious uveitis officially approved for marketing by the National Medical Products Administration

BEIJING, June 23, 2022 /PRNewswire/ -- Ocumension Therapeutics (1477.HK)announced that the New Drug...

2022-06-23 12:19 2449

An In-Depth Look at the Annual Performance of SZSE Core Indices Constituent Companies

SHENZHEN, China, June 6, 2022 /PRNewswire/ -- All constituents of the key indices of the Shenzhen S...

2022-06-06 19:38 2652

SZSE Makes New Progress in Implementing High-standard Two-way Opening-up ChiNext Index Becomes an Important Target for Foreign Investors to Invest in China A-shares

SHENZHEN, China, June 2, 2022 /PRNewswire/ -- The SZSE ChiNext Daily (2x) Leveraged Product recentl...

2022-06-02 17:30 2062

Ping An Overseas Holdings Announces Successfully Raising USD 300 Million for China New Economy Fund

HONG KONG, May 18, 2022   /PRNewswire/ -- China Ping An Insurance Overseas (Holdings) Limited, the ...

2022-05-18 16:15 1985

Peijia Medical Announces 2021 Annual Results

Dual Engines Promote Commercialization Total Revenue Increased by 253.2% HONG KONG, April 2,  2022 ...

2022-04-02 00:06 10168

Sirnaomics Announces Interim Data from Phase II Clinical Trial of STP705 for Treatment of Cutaneous Basal Cell Carcinoma

HONG KONG, Feb. 23, 2022 /PRNewswire/ -- Sirnaomics Ltd. ("Sirnaomics", stock code: 2257.HK), a lea...

2022-02-23 17:53 2663

Sirnaomics Receives Safe to Proceed Letter for U.S. FDA Investigational New Drug Application for Systemic RNAi Therapeutic STP707 in Primary Sclerosing Cholangitis (PSC)

HONG KONG, Feb. 16, 2022 /PRNewswire/ -- Sirnaomics Ltd. (the "Company" or " Sirnaomics", stock code...

2022-02-16 17:04 3067